MD503C2 - Pentapeptyd derivatives - Google Patents

Pentapeptyd derivatives

Info

Publication number
MD503C2
MD503C2 MD95-0391A MD950391A MD503C2 MD 503 C2 MD503 C2 MD 503C2 MD 950391 A MD950391 A MD 950391A MD 503 C2 MD503 C2 MD 503C2
Authority
MD
Moldova
Prior art keywords
derivatives
pentapeptyd
dna synthesis
independently
under
Prior art date
Application number
MD95-0391A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD503B1 (en
Inventor
Jan Erik Paulsen
Букхард РЕЙЧЕЛТ
Original Assignee
Nycomed Bioreg As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Bioreg As filed Critical Nycomed Bioreg As
Publication of MD503B1 publication Critical patent/MD503B1/en
Publication of MD503C2 publication Critical patent/MD503C2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/067Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The present invention relates to the pentapeptyd derivatives and particularly to the pentapeptidic compounds which manifest suppressive influence upon the DNA synthesis and mythotic rate under the liver regeneration, and also upon the DNA synthesis and hepatoma malignant cells line growth in vitro and in vivo. Peptapeptyd derivatives of general formula I:where X1, X2 and X3 represents independently one from another OH or NH2 under the condition that X2 and X3 both are not NH2; or X1 is OH, X2 is NH2 and X3 is OH; or X1, X2 and X3 each reprezents independently OH.
MD95-0391A 1988-09-13 1994-12-29 Pentapeptyd derivatives MD503C2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO884054A NO884054D0 (en) 1988-09-13 1988-09-13 NEW PENTAPEPTIME AND PROCEDURE FOR PREPARING THEREOF.
PCT/NO1989/000093 WO1990002754A1 (en) 1988-09-13 1989-09-12 New pentapeptide and a process for the preparation thereof
SU914895028A RU2010799C1 (en) 1988-09-13 1991-03-12 Derivatives of pentapeptides

Publications (2)

Publication Number Publication Date
MD503B1 MD503B1 (en) 1996-03-29
MD503C2 true MD503C2 (en) 1996-07-31

Family

ID=19891239

Family Applications (1)

Application Number Title Priority Date Filing Date
MD95-0391A MD503C2 (en) 1988-09-13 1994-12-29 Pentapeptyd derivatives

Country Status (19)

Country Link
EP (2) EP0434722A1 (en)
JP (1) JPH04501710A (en)
KR (1) KR900701830A (en)
CN (1) CN1041158A (en)
AT (1) ATE102215T1 (en)
AU (1) AU623687B2 (en)
DE (1) DE68913411T2 (en)
DK (1) DK43891A (en)
ES (1) ES2062024T3 (en)
FI (1) FI911219A0 (en)
HU (2) HU206373B (en)
LV (1) LV10289B (en)
MD (1) MD503C2 (en)
MY (1) MY104912A (en)
NO (2) NO884054D0 (en)
NZ (1) NZ230625A (en)
RU (1) RU2010799C1 (en)
WO (1) WO1990002754A1 (en)
ZA (1) ZA896944B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620957A (en) * 1989-07-14 1997-04-15 Smithkline Beecham Corporation Hemoregulatory peptides
TW222280B (en) * 1991-11-26 1994-04-11 Smithkline Beecham Corp
IL104323A0 (en) * 1992-01-10 1993-05-13 Smithkline Beecham Corp Hemoregulatory peptides
RU2297239C1 (en) * 2006-05-30 2007-04-20 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Peptide stimulating regeneration of liver tissue, pharmaceutical composition based on thereof and method for its using

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2591748A (en) 1949-12-23 1952-04-08 Hercules Powder Co Ltd Amphoteric cellulose derivatives
FR2110268B1 (en) 1970-10-07 1976-06-04 Minnesota Mining & Mfg
US4237253A (en) 1977-04-21 1980-12-02 L'oreal Copolymers, their process of preparation, and cosmetic compounds containing them
NO860752L (en) * 1985-06-26 1986-12-29 Bio Tech As PENTAPEPTIDES WITH CELL GROWTH REGULATORY EFFECTS AND PROCEDURES FOR PRODUCING THEREOF.
GB8626539D0 (en) * 1986-11-06 1986-12-10 Nycomed As Peptide compounds

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Brevet nr.WO 87/00180, Int. Cl. C 07 K 7/06, 1987. *
Ян Эрик Паульсен, Карл-Л. Рейхельт, Анна К. Петерсен, Purification and characterization of a growth inhibitory hepatic peptide, apreliminary note, Virehows Arch B. 54, 152-154, 1987. *

Also Published As

Publication number Publication date
KR900701830A (en) 1990-12-04
LV10289A (en) 1994-10-20
NZ230625A (en) 1991-06-25
ES2062024T3 (en) 1994-12-16
CN1041158A (en) 1990-04-11
EP0434722A1 (en) 1991-07-03
EP0360481A1 (en) 1990-03-28
FI911219A0 (en) 1991-03-12
DK43891D0 (en) 1991-03-12
JPH04501710A (en) 1992-03-26
LV10289B (en) 1995-04-20
HU895790D0 (en) 1991-11-28
ZA896944B (en) 1990-06-27
MY104912A (en) 1994-06-30
WO1990002754A1 (en) 1990-03-22
EP0360481B1 (en) 1994-03-02
DE68913411T2 (en) 1994-06-23
AU623687B2 (en) 1992-05-21
RU2010799C1 (en) 1994-04-15
DK43891A (en) 1991-03-12
HUT58766A (en) 1992-03-30
ATE102215T1 (en) 1994-03-15
NO884054D0 (en) 1988-09-13
HU206373B (en) 1992-10-28
DE68913411D1 (en) 1994-04-07
NO910933L (en) 1991-03-08
NO910933D0 (en) 1991-03-08
AU4224089A (en) 1990-04-02
MD503B1 (en) 1996-03-29

Similar Documents

Publication Publication Date Title
ES8505338A1 (en) Benzoyl urea derivatives having anti-tumor activity.
ZA936306B (en) Imidazolidine derivatives
PL309197A1 (en) Novel compositions based on taxoides
EP0565587A4 (en) The effect of n,n,n-trimethylsphingosine on protein kinase-c activity; melanoma cell growth -i(in vitro); metastatic potential -i(in vivo) and human platelet aggregation
EP0435321A3 (en) Novel a-nor-steroid-3-carboxylic acid derivatives
ES8801896A1 (en) Benzoyl urea derivatives having ati-tumor activity.
MY115211A (en) Novel amino acid derivatives, their preparation and use
BG101867A (en) Benzothiazenedioxides as endothelin antagonists
SI1077218T1 (en) Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors
BG100661A (en) Aryl acetic acid derivatives
EP2366712A3 (en) A tumor suppressor designated TS10Q23.3
GR3030733T3 (en) Sulphamate derivatives of 1,3,5(10)-estratriene derivatives, methods of producing them and pharmaceutical compounds containing them
NZ331875A (en) Asymmetric synthesis of R-alpha-propyl-piperonyl amine and its analogs
IL132599A0 (en) Substituted 3,3-diamino-2-propenenitriles their preparation and use
JPH0784481B1 (en)
MD503C2 (en) Pentapeptyd derivatives
ES8800910A1 (en) Substituted quinazolinediones.
BG103260A (en) The application of 1-hydroxy-2-pyridons for the treatment of seborrheic dermatitis
DE3767728D1 (en) Hydroxylierte 1,2-diamincyclohexan platinkomplexe.
EP0308792A3 (en) Azachromane derivatives
AU7895087A (en) Antigestagens for the inhibition of uterine synthesis of prostaglandin
IL83088A (en) Substituted 3-isoquinolinols,their preparation and pharmaceutical compositions containing them
ES8601849A1 (en) Novel aryloxycycloalkanolaminoalkylene aryl ketones.
MY107258A (en) 1-methoxypyrimidinyl-n-nitrophenyl-1h-1,2,4-triazole-3- sulphonamides, processes for their preparation and their use as herbicides.
SU1155587A1 (en) N,n,n-tri-tert-butyloxycarbonylarginine as semi-product for synthesis of arginine containing peptides

Legal Events

Date Code Title Description
FG4A Patent for invention issued
IF99 Valid patent on 19990615

Free format text: EXPIRES: 20110312